<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta name="description" content="No more spammy emails and notifications.
        Only unobtrusive news aggregation that you can review at your own pace.
    ">

    <title>Product News</title>
    <meta name="description" content="">

<!-- Facebook Meta Tags -->
<meta property="og:url" content="/379/">
<meta property="og:type" content="website">
<meta property="og:title" content="Product News">
<meta property="og:description" content="No more spammy emails and notifications. Only unobtrusive news aggregation that you can review at your own pace.">
<meta property="og:image" content="https://image.thum.io/get/crop/500/https://newsinproduct.com" name="image">
<meta name="author" content="Ivo Valchev">

<!-- Twitter Meta Tags -->
<meta name="twitter:card" content="summary_large_image">
<meta property="twitter:url" content="https://i-valchev.github.io/productnews/https://nocodeapi.com/">
<meta name="twitter:title" content="Product News">
<meta name="twitter:description" content="No more spammy emails and notifications. Only unobtrusive news aggregation that you can review at your own pace.">
<meta name="twitter:image" content="https://image.thum.io/get/crop/500/https://newsinproduct.com">


    <link rel="preconnect" href="https://fonts.gstatic.com">
    <link rel="icon" type="image/svg" href="/assets/favicon.svg">
    <link href="https://fonts.googleapis.com/css2?family=Newsreader:ital,wght@0,400;0,700;1,400;1,800&display=swap" rel="stylesheet">
    <link href="/assets/splendor.min.css" rel="stylesheet" />
    <link href="/assets/styles.css" rel="stylesheet" />
    <script src="/assets/luxon.min.js" defer="defer"></script>
    <script src="/assets/scripts.js" defer="defer"></script>

    <!-- Global site tag (gtag.js) - Google Analytics -->
    <script async src="https://www.googletagmanager.com/gtag/js?id=G-KMXG1NKPKT"></script>
    <script>
        window.dataLayer = window.dataLayer || [];
        function gtag(){dataLayer.push(arguments);}
        gtag('js', new Date());

        gtag('config', 'G-KMXG1NKPKT');
    </script>
</head>
<body>

<nav>
    <a href="/">Home</a> |
    <a href="/contact">Add feed</a>
</nav>




    <div class="list-container">
        <aside>
            <p>
                Right now, there are 6660 aggregated posts from 15 publications.
                Last updated <span data-relative-time="2023-04-03T10:00:32.053+00:00">Monday 3 April 2023</span>
            </p>
        </aside>

        <main role="main">
            
                <article>
                    <h3><a href="https://medium.com/swlh/4-tools-that-2xed-my-content-output-in-half-the-time-269bdefd2ef6?source=rss----f5af2b715248---4" target="_blank" rel="noreferrer">4 Tools that 2X’ed My Content Output in Half The Time</a></h3>
                    <section>
                        
                        <p>
                            Published
                            
                             on Monday 27 June 2022
                        </p>
                    </section>
                </article>
                <hr>
            
                <article>
                    <h3><a href="https://www.technologyreview.com/2022/06/27/1054989/download-facebook-misleading-cancer-ads-treatment-unproven-hacking-nso-group-us/" target="_blank" rel="noreferrer">The Download: Facebook’s misleading cancer ads, and hacking’s next era</a></h3>
                    <section>
                         <p><em>This is today&#8217;s edition of <a href="https://forms.technologyreview.com/newsletters/briefing-the-download/?_ga=2.179569122.736533416.1649661040-405833893.1649413289">The Download</a></em>,<em> our weekday newsletter that provides a daily dose of what&#8217;s going on in the world of technology.</em></p> <p class="has-medium-font-size"><strong>Facebook is bombarding cancer patients with ads for unproven treatments</strong><a href="https://www.technologyreview.com/2022/06/27/1054784/facebook-meta-cancer-treatment-ads-misinformation/?truid=*%7CLINKID%7C*&amp;utm_source=the_download&amp;utm_medium=email&amp;utm_campaign=the_download.unpaid.engagement&amp;utm_term=*%7CSUBCLASS%7C*&amp;utm_content=*%7CDATE:m-d-Y%7C*"></a></p> <p>The ad reads like an offer of salvation: Cancer kills many people. But there is...</p>
                        <p>
                            Published
                            
                             on Monday 27 June 2022
                        </p>
                    </section>
                </article>
                <hr>
            
                <article>
                    <h3><a href="https://medium.com/swlh/my-5-minute-guide-to-making-a-high-converting-sub-1-2-second-landing-page-28cc5861b3a5?source=rss----f5af2b715248---4" target="_blank" rel="noreferrer">My 5-Minute Guide To Making A High-Converting Sub 1.2 Second Landing Page</a></h3>
                    <section>
                        
                        <p>
                            Published
                            
                             on Monday 27 June 2022
                        </p>
                    </section>
                </article>
                <hr>
            
                <article>
                    <h3><a href="https://www.technologyreview.com/2022/06/27/1054784/facebook-meta-cancer-treatment-ads-misinformation/" target="_blank" rel="noreferrer">Facebook is bombarding cancer patients with ads for unproven treatments</a></h3>
                    <section>
                         <p>The ad reads like an offer of salvation: Cancer kills many people. But there is hope in Apatone, a proprietary vitamin C–based mixture, that is “KILLING cancer.” The substance, an unproven treatment that is not approved by the FDA, is not available in the United States. If you want Apatone,...</p>
                        <p>
                            Published
                            
                             on Monday 27 June 2022
                        </p>
                    </section>
                </article>
                <hr>
            
                <article>
                    <h3><a href="https://www.technologyreview.com/2022/06/27/1054974/metaverse-open-for-business/" target="_blank" rel="noreferrer">Metaverse: Open for business?</a></h3>
                    <section>
                         <p>Ever since Facebook’s rebrand to Meta, the metaverse—loosely defined as an extensive online world where interactions happen via digital avatars—has gone mainstream as part of “web3,” the internet’s third act in which users move from consumers to creators to residents in online worlds.</p> <p>The entertainment and gaming industries are at...</p>
                        <p>
                            Published
                            
                             on Monday 27 June 2022
                        </p>
                    </section>
                </article>
                <hr>
            
            <nav>
                
                    <a href="/378/">Previous</a>
                

                
                    <a href="/380/">Next</a>
                
            </nav>
        </main>
    </div>


</body>
</html>
